Wall Street analysts lift Boeing, start Clover Health amid fresh calls on U.S. stocks

Traders Union
All News
Stocks
Wall Street analyst calls

Highlights

Langenberg & Company upgrades Boeing to buy with a $250 price target, citing opportunity despite production delays in 737 and 787.
Needham initiates Clover Health at buy with a $6 target, and Guggenheim starts Madison Square Garden Rangers at buy with a $278 target post-spin-off.
Stifel downgrades Whirlpool to sell and cuts target to $20 after weak results, while Chemed and Instacart receive split analyst views on turnaround potential.

Brokerage calls reshape outlook across sectors

Langenberg & Company, as reported by CNBC, upgrades Boeing to buy from hold after the planemaker's earnings and sets a $250 price target, saying there is room to re-enter the stock despite delays in commercial airplane production increases for the 737 and 787.

Elsewhere, Needham initiates Clover Health with a buy rating and a $6 price target, citing a compelling earnings opportunity, while Guggenheim starts Madison Square Garden Rangers at buy with a $278 target after the company becomes publicly traded following its spin-off from MSG Knickerbockers. Roth also initiates Anfield Energy with a buy rating and a U.S.$5.00 price target, arguing the energy company is undervalued.

Several firms reiterate positive views on large-cap names. Bernstein keeps Robinhood at outperform after earnings, saying record volumes, pricing trade-offs, prediction markets and new products can support the next leg of growth. Evercore ISI reiterates Apple at outperform after Mac and iPad upgrade announcements, and Truist maintains its buy rating on Amazon ahead of Thursday earnings, expecting results near the high end of market expectations.

Yorkville Ives also reiterates Meta and Nvidia at outperform, pointing to their partnership as a key advantage in the next wave of artificial intelligence spending. Daiwa, meanwhile, keeps SpaceX at neutral but raises its price target to $159 from $140, reflecting higher valuations across its three segments, while Susquehanna reiterates Advanced Micro Devices at buy and lifts its target to $650 from $620 ahead of third-quarter earnings.

Market implications for industrial and consumer stocks

The latest calls also highlight a split view on turnaround and risk-sensitive names. Jefferies upgrades Chemed to buy from neutral, arguing the hospice and plumbing company is emerging from operating issues that hurt earnings visibility and can rebuild a record of stability and growth.

By contrast, Gordon Haskett downgrades Instacart to hold from buy, saying any upside from a possible deal with DoorDash is balanced by downside risk if an agreement does not emerge. Wolfe reiterates Tesla at peer perform, saying the setup is improving even as the electric vehicle maker enters a period of significant cash burn.

In consumer durables, Stifel cuts Whirlpool to sell from hold after disappointing quarterly results and lowers its target price to $20. The breadth of Wednesday's analyst actions suggests investors are continuing to favor companies with clearer earnings momentum, product catalysts or restructuring progress, while remaining cautious on names facing execution risk or weaker demand trends.

In our earlier coverage of the S&P 500’s push toward 8,000, we examined how the midsummer, AI-led rally was running into a tougher test from higher oil prices, elevated Treasury yields, and election-related uncertainty. That piece also warned about narrow market breadth and concentration risk, noting that a large share of index components were trading below key moving averages even near record highs.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.